Flagship Pioneering as of June 30, 2020
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 8 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 74.4 | $2.6B | 40M | 64.21 | |
| Rubius Therapeutics | 6.7 | $229M | 38M | 5.98 | |
| Denali Therapeutics (DNLI) | 5.6 | $193M | 8.0M | 24.18 | |
| Kaleido Biosciences Ord (KLDO) | 4.2 | $144M | 19M | 7.43 | |
| Evelo Biosciences | 3.3 | $112M | 23M | 4.90 | |
| Seres Therapeutics | 3.0 | $103M | 22M | 4.76 | |
| Axcella Health Inc equity | 2.0 | $69M | 13M | 5.53 | |
| Syros Pharmaceuticals | 0.9 | $31M | 2.9M | 10.66 |
